J.P. Morgan Reaffirms Their Hold Rating on Roche Holding AG (RHHVF)
In a report released today, Richard Vosser from J.P. Morgan maintained a Hold rating on Roche Holding AG, with a price target of CHF325.00.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Vosser covers the Healthcare sector, focusing on stocks such as Roche Holding AG, Sanofi, and Novo Nordisk. According to TipRanks, Vosser has an average return of 0.8% and a 46.34% success rate on recommended stocks.
In addition to J.P. Morgan, Roche Holding AG also received a Hold from TipRanks – Anthropic’s Anthropic Drug Manufacturers – General in a report issued today. However, on the same day, Barclays maintained a Buy rating on Roche Holding AG (Other OTC: RHHVF).
The company has a one-year high of CHF374.90 and a one-year low of CHF231.90. Currently, Roche Holding AG has an average volume of 1.14M.
Read More on RHHVF:
Disclaimer & DisclosureReport an Issue
- Xencor reports receipt of notice of termination of license agreement from Roche
- H.C. Wainwright does not see direct read from Roche miss to Olema’s OPERA-02
- Genentech announces persevERA Breast Cancer study did not meet primary endpoint
- Controversial Prasad leaving FDA, NYT reports
- Roche Chairman says diagnostics division exposed to tariffs, Reuters says
